Experience

Yeda - Technology Transfer Company of Weizmann Institute of Science

• Israel
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Director Of Business Development

  • Jul 2020 - Present

  Yeda R&D is the technology transfer and innovation entity of the Weizmann Institute of Science. As Director of Business Development, I am leading the commercialization of Weizmann-made technologies in the Life Sciences sector, focusing on Pharma and Biotech. Yeda R&D is the technology transfer and innovation entity of the Weizmann Institute of Science. As Director of Business Development, I am leading the commercialization of Weizmann-made technologies in the Life Sciences sector, focusing on Pharma and Biotech.


WE@HealthTech
• Israel
• Health and Human Services
• 1 - 100 Employee
• Member

  • Feb 2021 - Present


Sentaur Biosciences

• Board Observer

  • Sep 2020 - Present

  The company develops antibodies to specifically target senescent cells. The technology comes from the Weizmann Institute, from the lab of Prof. Valery Krizhanovsky, a world renown expert in the field of Senescence Cells. The team developed a unique MS based discovery method to identify novel targets onto the surface of senescence cells. Sentaur Biosciences focuses on those identified targets and develops antibodies to target and eliminate the senescent cells The company develops antibodies to specifically target senescent cells. The technology comes from the Weizmann Institute, from the lab of Prof. Valery Krizhanovsky, a world renown expert in the field of Senescence Cells. The team developed a unique MS based discovery method to identify novel targets onto the surface of senescence cells. Sentaur Biosciences focuses on those identified targets and develops antibodies to target and eliminate the senescent cells



Compugen

• Israel
• Biotechnology Research
• 1 - 100 Employee

• Project Leader

  • Nov 2018 - Jul 2020

  Design and establishment of experimental systems for functional validation of novel immunomodulatory molecules for oncology indications.Investigating fundamental aspects of human and mouse biology and translating the discoveries into novel therapeutic approaches.

• Scientist

  • Jan 2017 - Jul 2020


Efranat Ltd.
• Research Scientist

  • 2015 - Feb 2017


Weizmann Institute of Science

• Israel
• Research
• 700 & Above Employee

• Post-doc researcher, Department of Immunology

  • 2014 - 2016

  Investigating the role of novel subset of DCs in metabolic syndrome, autoimmunity and cancer. Investigating the role of novel subset of DCs in metabolic syndrome, autoimmunity and cancer.


Madatech - National Museum of Science Technology and Space, Haifa
• Israel
• Museums, Historical Sites, and Zoos
• 1 - 100 Employee
• Guide

  • Jun 2003 - Aug 2006